The Arab Drug Company (EGX: ADCI)

Market Cap	848.34M
Revenue (ttm)	827.61M
Net Income (ttm)	95.67M
Shares Out	6.00M
EPS (ttm)	15.95
PE Ratio	8.87
Forward PE	n/a
Dividend	8.35 (5.91%)
Ex-Dividend Date	Oct 28, 2024

Volume	198
Average Volume	7,465
Open	141.39
Previous Close	141.39
Day's Range	138.45 - 139.95
52-Week Range	72.00 - 148.00
Beta	0.57
RSI	81.21
Earnings Date	Feb 13, 2025

About The Arab Drug Company

The Arab Drug Company engages in the manufacture and sale of pharmaceutical products. It offers anti-infectives, central nervous system drugs, dermatological drugs, and cardiovascular drugs, as well as animal health products in powders and solutions. The company exports its products to approximately 40 countries, including China, Korea, Turkey, Kazakhstan, Iraq, Syria, Jordan, Lebanon, Libya, Sudan, Somalia, Yemen, and Morocco. The Arab Drug Company was incorporated in 1963 and is based in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 1963
• Employees: 1,148
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: ADCI

Financial Performance

In 2024, The Arab Drug Company's revenue was 785.52 million, an increase of 23.95% compared to the previous year's 633.73 million. Earnings were 88.35 million, an increase of 24.21%.